Literature DB >> 14648823

Detoxification of 4-hydroxynonenal (HNE) in keratinocytes: characterization of conjugated metabolites by liquid chromatography/electrospray ionization tandem mass spectrometry.

Giancarlo Aldini1, Paola Granata, Marica Orioli, Enzo Santaniello, Marina Carini.   

Abstract

Keratinocytes are potential targets of lipid peroxidation products (alpha,beta-unsaturated aldehydes) generated in the skin following UV exposure, among which the most abundant and toxic product is 4-hydroxy-trans-2,3-nonenal (HNE). The aim of this study was to investigate the ability of keratinocytes (NCTC2544 cell lines) to detoxify HNE, through characterization of metabolites, until now never demonstrated, using a combined analytical approach (liquid chromatography (LC) and liquid chromatography/mass spectrometry (LC/MS)). Incubation of cells with HNE (up to 200 micro M) was performed in order to evaluate the ability of the cells to detoxify this toxic aldehyde, and indicated that the cell viability was maintained under these conditions. LC analysis of the extracellular media from keratinocytes incubated with 100 micro M HNE shows a time-dependent decrease of HNE, disappearance from the medium within 2 h and concomitant formation of two unconjugated (phase I) metabolites, 4-hydroxy-2-nonenoic acid (HNA) and 1,4-dihydroxy-2-nonene (DHN), which were both identified and quantified by LC and accounted for 48.8 +/- 4.6% of the HNE dose. Four additional metabolites were identified in the extracellular medium by reversed-phase LC coupled with electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) with positive and negative ion detection as Michael adducts (phase II metabolites), arising by the addition of the nucleophilic sulfur of glutathione (GSH) to the electrophilic C-3 of HNE, followed by oxidation-reduction enzymatic processes. The GSH-HNE conjugates were (a) S-(4-hydroxynonanal-3-yl)glutathione, (b) S-(1,4-dihydroxy-nonane-3-yl)glutathione, (c) S-(4-oxononanal-3-yl)glutathione and (d) S-(4-oxo-nonan-1-ol-3-yl)glutathione, and accounted for 52.3 +/- 5.8% of the HNE dose (35 nmol mg(-1) protein), as estimated indirectly by measuring the extent of cellular GSH consumption (18.7 +/- 1.8 nmol mg(-1) protein). The time course of HNE biotransformation was then determined by monitoring the formation of metabolites inside and outside the cell at different times after HNE addition (5-120 min). A time-dependent and almost linear formation inside the cell was observed for all the metabolites (plateau after 15 min of incubation), followed by a rapid decay and a concomitant increase in the extracellular medium (plateau of formation after 60 min). This confirms that HNE diffuses into the cell where is totally metabolized through phase I and phase II reactions to unreactive products, which are then exported outside the cell. This is the first demonstration that skin epidermal cells are able to detoxify the cytotoxic products of lipid peroxidation. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648823     DOI: 10.1002/jms.533

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  18 in total

1.  Mitigation of radiation-induced dermatitis by activation of aldehyde dehydrogenase 2 using topical alda-1 in mice.

Authors:  Shoucheng Ning; Grant R Budas; Eric N Churchill; Che-Hong Chen; Susan J Knox; Daria Mochly-Rosen
Journal:  Radiat Res       Date:  2012-03-09       Impact factor: 2.841

2.  Metabolism of 4-Hydroxy-7-oxo-5-heptenoic Acid (HOHA) Lactone by Retinal Pigmented Epithelial Cells.

Authors:  Hua Wang; Mikhail Linetsky; Junhong Guo; Annabelle O Yu; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-07-07       Impact factor: 3.739

Review 3.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Authors:  Che-Hong Chen; Julio Cesar Batista Ferreira; Eric R Gross; Daria Mochly-Rosen
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 4.  Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; K Guth; R Landsiedel
Journal:  Arch Toxicol       Date:  2014-11-05       Impact factor: 5.153

5.  Catabolism of 4-hydroxy-2-trans-nonenal by THP1 monocytes/macrophages and inactivation of carboxylesterases by this lipid electrophile.

Authors:  Abdolsamad Borazjani; Mariola J Edelmann; Katelyn L Hardin; Katye L Herring; J Allen Crow; Matthew K Ross
Journal:  Chem Biol Interact       Date:  2011-08-22       Impact factor: 5.192

Review 6.  High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites.

Authors:  M Holcapek; L Kolárová; M Nobilis
Journal:  Anal Bioanal Chem       Date:  2008-03-15       Impact factor: 4.142

7.  Modulation of keratinocyte expression of antioxidants by 4-hydroxynonenal, a lipid peroxidation end product.

Authors:  Ruijin Zheng; Diane E Heck; Vladimir Mishin; Adrienne T Black; Michael P Shakarjian; Ah-Ng Tony Kong; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-11       Impact factor: 4.219

8.  Experimental and computational studies investigating trehalose protection of HepG2 cells from palmitate-induced toxicity.

Authors:  Sukit Leekumjorn; Yifei Wu; Amadeu K Sum; Christina Chan
Journal:  Biophys J       Date:  2007-12-20       Impact factor: 4.033

9.  Ascorbic acid promotes detoxification and elimination of 4-hydroxy-2(E)-nonenal in human monocytic THP-1 cells.

Authors:  Cristobal L Miranda; Ralph L Reed; Heather C Kuiper; Susan Alber; Jan F Stevens
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

10.  4-Hydroxy-7-oxo-5-heptenoic acid (HOHA) lactone induces apoptosis in retinal pigment epithelial cells.

Authors:  Mikhail Linetsky; Junhong Guo; Emeka Udeigwe; Duoming Ma; Amanda S Chamberlain; Annabelle O Yu; Kseniya Solovyova; Elise Edgar; Robert G Salomon
Journal:  Free Radic Biol Med       Date:  2020-03-25       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.